Cargando…
Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trial
BACKGROUND: The single most distressing symptom for patients with advanced esophageal cancer is dysphagia. Amongst the more effective treatments for relief of dysphagia is insertion of a self-expanding metal stent (SEMS). It is possible that the addition of a palliative dose of external beam radioth...
Autores principales: | Adamson, Douglas, Blazeby, Jane, Nelson, Annmarie, Hurt, Chris, Nixon, Lisette, Fitzgibbon, Jim, Crosby, Tom, Staffurth, John, Evans, Mim, Kelly, Noreen Hopewell, Cohen, David, Griffiths, Gareth, Byrne, Anthony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223756/ https://www.ncbi.nlm.nih.gov/pubmed/25336193 http://dx.doi.org/10.1186/1745-6215-15-402 |
Ejemplares similares
-
Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial
por: Adamson, Douglas, et al.
Publicado: (2021) -
Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy
por: Wills, Lucy, et al.
Publicado: (2017) -
Driving developments in UK oesophageal radiotherapy through the SCOPE trials
por: Gwynne, S., et al.
Publicado: (2019) -
Oesophageal Stents for Potentially Curable Oesophageal Cancer – A Bridge to Surgery?
por: Tham, Jennifer E, et al.
Publicado: (2019) -
Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer
por: Rees, J, et al.
Publicado: (2015)